COVID-19: The Multifaceted Search for Potential Treatments

Gabrielle Ientile

March 25, 2020

Greg Frank, PhD, director of Working to Fight AMR and director of infectious disease policy at the Biotechnology Innovation Organization, sees the COVID-19 outbreak as potentially an issue related to antimicrobial resistance.

“Much of our modern medical care is reliant on antibiotics,” Dr Frank said in an interview with Drug Topics®…

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

Join senior editor Andrea Corona and Emily Wheeler, Director of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO), as…

Putting a face on the ‘invisible threat’ of antimicrobial resistance

Mallory Smith was a young woman who, in her own words, had "big dreams and big goals." When she was…

How the pandemic gave power to superbugs

Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…

Name
First Last
Email
Zipcode
Organization
Title
Name
This field is for validation purposes and should be left unchanged.

Drug Topics

COVID-19: The Multifaceted Search for Potential Treatments

Gabrielle Ientile

March 25, 2020

More

Off Script: A Pharma Manufacturing Podcast

Antibiotic resistance crisis and the global efforts against superbugs

CIDRAP

Putting a face on the ‘invisible threat’ of antimicrobial resistance

NPR

How the pandemic gave power to superbugs

Wall Street Journal

The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably.

Sign up for the latest on fighting AMR